Wells Fargo lowered the firm’s price target on Intuitive Surgical to $363 from $386 and keeps an Overweight rating on the shares. Intuitive Surgical’s EPS was above expectations, though revenue was below consensus, the analyst tells investors in a research note. Intuitive saw strong procedure growth in Q3, with strength in both the U.S. and OUS, and bariatric surgery growth was up double digits despite slowing in the U.S. vs. Q2, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical price target lowered to $315 from $375 at Stifel
- Intuitive Surgical price target lowered to $312 from $320 at Baird
- Intuitive Surgical price target lowered to $390 from $400 at Citi
- Intuitive Surgical raises FY23 procedure growth to up 21%-22% from 20%-22%
- Intuitive Surgical (NASDAQ:ISRG) Plunges on Q3 Revenue Miss